Control:Article Title: Identification and characterization of amphipathic antimicrobial peptides with broad spectrum activity against multi-drug resistant bacteria.
Article Snippet: .. Strain Characteristics Reference S. aureus ATCC 29213 Control strain for antimicrobial activity assays ATCC, USA S. aureus MRSA USA 300 Clinical isolate, MRSA [41] P. aeruginosa ATCC 27853 Control strain for antimicrobial activity assays ATCC, USA P. aeruginosa (ST175-1) Clinical isolate, panresistant [42] A. baumannii ATCC 19606 Reference bacterial strain ATCC, USA A. baumannii IB010 ATCC 19606 derivative deficient in lipooligosaccharide due to a large deletion in the lpxD gene, colistin resistant [43] A. baumannii Ab-1 Clinical isolate, panresistant [44] K. pneumoniae ATCC 43816 Reference bacterial strain ATCC, USA K. pneumoniae CG258 Clinical isolate [45] E. coli ATCC 25922 Control strain for antimicrobial activity assays ATCC, USA E. coli ESBL 1057.1 Clinical isolate, resistant to 18 antibiotics [46] Table 3. .. Minimum inhibitory concentration (MIC) and Minimum Bactericidal Concentration (MBC) of peptides BP76, BP145 and BP607 against the different bacterial strains BP76 BP145 BP607 MIC (μg/ml) MBC (μg/ml) MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) MBC (μg/ml) S. aureus ATCC 29213 25 25 50 50 50 50 S. aureus MRSA USA 300 50 50 50 50 50 50 P. aeruginosa ATCC 27853 50 50 50 50 25 25 P. aeruginosa (ST175-1) 50 50 50 50 50 100 A. baumannii ATCC 19606 6.25 6.25 6.25 6.25 3.13 6.25 A. baumannii IB010 25 25 25 25 25 50 A. baumannii Ab-1 12.5 12.5 12.5 12.5 6.25 6.25 K. pneumoniae ATCC 43816 12.5 12.5 25 25 12.5 12.5 K. pneumoniae CG258 6.25 6.25 12.5 12.5 12.5 12.5 E. coli ATCC 25922 6.25 6.25 6.25 6.25 6.25 6.25 E. coli ESBL 1057.1 12.5 12.5 12.5 12.5 12.5 12.5 FIGURE LEGENDS Figure 1.
Activity Assay:Article Title: Identification and characterization of amphipathic antimicrobial peptides with broad spectrum activity against multi-drug resistant bacteria.
Article Snippet: .. Strain Characteristics Reference S. aureus ATCC 29213 Control strain for antimicrobial activity assays ATCC, USA S. aureus MRSA USA 300 Clinical isolate, MRSA [41] P. aeruginosa ATCC 27853 Control strain for antimicrobial activity assays ATCC, USA P. aeruginosa (ST175-1) Clinical isolate, panresistant [42] A. baumannii ATCC 19606 Reference bacterial strain ATCC, USA A. baumannii IB010 ATCC 19606 derivative deficient in lipooligosaccharide due to a large deletion in the lpxD gene, colistin resistant [43] A. baumannii Ab-1 Clinical isolate, panresistant [44] K. pneumoniae ATCC 43816 Reference bacterial strain ATCC, USA K. pneumoniae CG258 Clinical isolate [45] E. coli ATCC 25922 Control strain for antimicrobial activity assays ATCC, USA E. coli ESBL 1057.1 Clinical isolate, resistant to 18 antibiotics [46] Table 3. .. Minimum inhibitory concentration (MIC) and Minimum Bactericidal Concentration (MBC) of peptides BP76, BP145 and BP607 against the different bacterial strains BP76 BP145 BP607 MIC (μg/ml) MBC (μg/ml) MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) MBC (μg/ml) S. aureus ATCC 29213 25 25 50 50 50 50 S. aureus MRSA USA 300 50 50 50 50 50 50 P. aeruginosa ATCC 27853 50 50 50 50 25 25 P. aeruginosa (ST175-1) 50 50 50 50 50 100 A. baumannii ATCC 19606 6.25 6.25 6.25 6.25 3.13 6.25 A. baumannii IB010 25 25 25 25 25 50 A. baumannii Ab-1 12.5 12.5 12.5 12.5 6.25 6.25 K. pneumoniae ATCC 43816 12.5 12.5 25 25 12.5 12.5 K. pneumoniae CG258 6.25 6.25 12.5 12.5 12.5 12.5 E. coli ATCC 25922 6.25 6.25 6.25 6.25 6.25 6.25 E. coli ESBL 1057.1 12.5 12.5 12.5 12.5 12.5 12.5 FIGURE LEGENDS Figure 1.
|
ATCC is a verified supplier 
ATCC manufactures this product 